Joshua Omale, Pediatric Oncology Advocate, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared a post on LinkedIn:
”CHAPTER 8 Every Generation redraws the map of Disease
Why the Future of Medicine depends on seeing what previous Generations could not. Every generation inherits the scientific map drawn by those before it.
There was a time when disease was understood only through symptoms.
- Fever
- Pain
- Weight loss
- Bleeding
Medicine learned to recognize patterns long before it understood their causes. Then came anatomy. Disease acquired a location.
Organs replaced symptoms as the centre of medical understanding. Later, pathology transformed medicine again. Disease became something that could be seen under the microscope.
Cells revealed truths that symptoms alone never could. Each revolution changed not only what medicine knew, it changed how medicine saw. Today, we are living through another transformation.
For perhaps the first time in history, we are beginning to map disease at molecular resolution.
- Genes
- Proteins
- Immune signalling
- Cell-to-cell communication
- Epigenetic regulation
- Microbiomes
- Spatial biology
The diseases themselves have not fundamentally changed. Our vision has, through these new ways of seeing.
What was once called ‘one disease’ increasingly becomes many molecular subtypes.
What once seemed biologically identical now reveals profoundly different pathways of progression, treatment response, and survival.
This is why genomics, molecular diagnostics, biomarkers, artificial intelligence, and precision medicine matter. Not because they represent the newest technologies. But because they allow medicine to redraw the map.
Every improvement in how we see disease changes how we classify it.
How we study it. How we treat it. And ultimately, how children survive it.
For Africa, this moment presents an extraordinary opportunity. We are not merely observers of a new scientific era. We must become contributors to the map itself.
If African children remain underrepresented in genomic databases, molecular profiling, biomarker discovery, and translational research, then tomorrow’s map of disease will be incomplete.
Not because African biology is fundamentally different, but because the scientific picture will remain unfinished.
That is not only a research challenge. It is a question of scientific equity.
The future of children’s health will belong to those who see more clearly, not only through better technology, but through broader representation, deeper collaboration, and a commitment to ensuring that every child’s biology helps shape humanity’s understanding of disease.
Because every generation redraws the map of disease. The question is whether every child will appear on it.
Building at the intersection of science, systems, and leadership for the future of children’s health in Africa.”
Other articles featuring Precision Medicine On OncoDaily.